Sun W, Li X
Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zhonghua Zhong Liu Za Zhi. 2021 Feb 23;43(2):224-227. doi: 10.3760/cma.j.cn112152-20200925-00852.
To evaluate emergency interventional embolization in treating intractable tumor bleeding in head and neck cancer. From February 2017 to February 2019, a total of 21 patients underwent emergency interventional embolization for the management of intractable tumor bleeding in head and neck cancer in Cancer Hospital, Chinese Academy of Medical Sciences. The tumor treatment history, bleeding history, angiography performance, technical success rate, clinical success rate and complications were retrospectively analyzed. The positive rate of angiography was 100% (21/21). Selective angiogram revealing abnormal tumor staining in 11 cases, contrast media extravasation in 5 cases, pseudoaneurysm in 2 cases, arteriovenous malformation in 2 cases and external carotid artery rupture in 1 case. One patient with carotid rupture was transferred to a general hospital for treatment. The remaining 20 patients received a total of 22 times of interventional embolization. The technical success rate was 100% (22/22). Recurrence occurred in 4 patients within 30 days, and the clinical success rate was 80%(16/20). Mild maxillofacial pain occurred in 5 patients (25.0%) and no serious complications occurred. Emergency interventional embolization is safe and effective for the management of intractable tumor bleeding in head and neck cancer.
评估急诊介入栓塞术治疗头颈部肿瘤难治性出血的效果。2017年2月至2019年2月，中国医学科学院肿瘤医院共有21例患者因头颈部肿瘤难治性出血接受急诊介入栓塞治疗。对患者的肿瘤治疗史、出血史、血管造影表现、技术成功率、临床成功率及并发症进行回顾性分析。血管造影阳性率为100%（21/21）。选择性血管造影显示11例肿瘤染色异常，5例造影剂外渗，2例假动脉瘤，2例动静脉畸形，1例颈外动脉破裂。1例颈动脉破裂患者转至综合医院治疗。其余20例患者共接受22次介入栓塞治疗。技术成功率为100%（22/22）。4例患者在30天内复发，临床成功率为80%（16/20）。5例患者（25.0%）出现轻度颌面疼痛，未发生严重并发症。急诊介入栓塞术治疗头颈部肿瘤难治性出血安全有效。
